Mizuho’s Jared Holz on Merck and Pfizer Q4 results, 2025 outlook for Big Pharma stocks

February 4, 2025
Mizuho’s Jared Holz on Merck and Pfizer Q4 results, 2025 outlook for Big Pharma stocksMizuho’s Jared Holz on Merck and Pfizer Q4 results, 2025 outlook for Big Pharma stocks
Share This

Jared Holz, Mizuho Securities America healthcare sector strategist, joins ‘Squawk Box’ to break down the quarterly earnings results of Merck and Pfizer, 2025 outlook for pharmaceutical stocks, and more.

Latest Mizuho News

See all news
Mizuho Expands “A Name Worth Knowing Award” to Support Two Promising Junior Golfers

Mizuho Expands “A Name Worth Knowing Award” to Support Two Promising Junior Golfers

May 8, 2026
Head of Investment and Corporate Banking Michal Katz on Bloomberg The Close (Starts at 1:15)

Head of Investment and Corporate Banking Michal Katz on Bloomberg The Close (Starts at 1:15)

April 29, 2026
All eyes on Coinbase after Robinhood's crypto revenue falls 47%

All eyes on Coinbase after Robinhood's crypto revenue falls 47%

May 5, 2026

Mizuho news from around the globe

 Mizuho Global News
back-to-top-blue